The Beauty Health Company (NASDAQ:SKIN) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET
Company Participants
Norberto Aja - Investor Relations
Marla Beck - President and CEO
Mike Monahan - CFO
Conference Call Participants
Oliver Chen - TD Cowen
Ashley Helgans - Jefferies
Allen Gong - JPMorgan
Susan Anderson - Canaccord Genuity
Bruce Jackson - Benchmark Company
Jon Block - Stifel
Linda Bolton Weiser - DA Davidson
Korinne Wolfmeyer - Piper Sandler
Olivia Tong - Raymond James
Operator
Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode. [Operator Instructions]. Please note this event is being recorded.
I would now like to turn the conference over to Norberto Aja of Investor Relations. Please go ahead.
Norberto Aja
Thank you, operator, and good afternoon, everyone. Thanks for joining the Beauty Health Company's conference call to discuss our Q3, 2024 Financial Results, which were released earlier this afternoon and which can be found on our corporate website at beautyhealth.com.
Joining me on the call today is Beauty Health Chief Executive Officer, Marla Beck; along our Chief Financial Officer, Mike Monahan. Before we begin, however, I would like to remind everyone of the company's safe harbor language. Management may make forward looking statements, including guidance and underlying assumptions. Forward looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. Listeners are cautioned not to place undue reliance on any forward-looking statements. For a further discussion of risks related to our business, please see the company's filings with the SEC.
This call will present non-GAAP financial measures. A reconciliation of these non-GAAP measures to the most comparable GAAP measure are in the earnings press release furnished to the SEC and available on our website. Following management's prepared remarks, we will open the call for a question and answer session.
With that, I would now like to turn the call over to our CEO, Marla Beck. Please go ahead, Marla.
Marla Beck
Thank you, Norberto. Good afternoon and thank you for joining us today to review our Q3 results. In my short time as CEO, we've identified and made significant progress addressing the most critical issues facing the company.
I believe we are in a much stronger position today. Our strategic initiatives have begun to take hold and are starting to flow through to our financial results. Third quarter revenue came in above the midpoint of our guidance, we lowered our operating expenses versus the prior year and delivered profitable adjusted EBITDA despite top line pressures across device sales. Strong growth in consumables allowed us to make great strides in improving our adjusted gross margin to 69%.